- Investing Ideas
- Indian Pharmaceuticals & Biotech High Return On Equity, Low Debt
Indian Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
3
0 new
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
3 companies
Abbott India
Market Cap: ₹549.3b
Abbott India Limited, junto con sus filiales, opera como empresa farmacéutica en la India.
500488
₹25,850.45
7D
1.0%
1Y
-25.6%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹405.3b
GlaxoSmithKline Pharmaceuticals Limited fabrica, distribuye y comercializa productos farmacéuticos en la India y a escala internacional.
500660
₹2,392.75
7D
1.4%
1Y
-27.2%
Sanofi India
Market Cap: ₹78.9b
Sanofi India Limited fabrica y comercializa medicamentos y productos farmacéuticos en India, Singapur y a escala internacional.
500674
₹3,426.05
7D
1.9%
1Y
-43.7%